In This Section

CICR Communications Subcommittee

Keith R. Hornberger, PhD
Chair

Keith R. Hornberger, PhD

(2021-2022)

Director, Chemistry
Arvinas
, Inc. 
New Haven, Connecticut

Iain D.G. Watson, PhD
Past Chair

Iain D.G. Watson, PhD

(2021-2022)

Senior Scientist, Drug Discovery
Ontario Institute for Cancer Research
Ontario, Canada 

Martin E. Swarbrick, PhD
Chair-Elect

Martin E. Swarbrick, PhD

(2021-2022)

Director of R&D Chemistry
Ryvu Therapeutics SA
Krakow, Poland

Barbara Czako, PhD

Barbara Czako, PhD

(2021-2023)

Principal Scientist, Therapeutics Discovery
MD Anderson Cancer Center
 
Houston, Texas

Adrian Gill, PhD

Adrian Gill, PhD

(2021-2022)

Vice President, Medicinal Chemistry
Revolution Medicines
 
Redwood City, California 

Dennis X. Hu, PhD

Dennis X. Hu, PhD

(2021-2023)

Senior Scientist, Small Molecule Drug Discovery
Genentech

South San Francisco, California 

Lyn Howard Jones, PhD

Lyn Howard Jones, PhD

(2021-2023)

Chief Scientist, Center for Protein Degradation
Dana-Farber Cancer Institute
 
Boston, Massachusetts 

Laetitia Martin, PhD

Laetitia Martin, PhD

(2021-2022)

Small Molecule Research Liaison for Oncology;
Project Team Leader
F. Hoffmann-La Roche
Basel, Switzerland